Tonix Pharmaceuticals Company
Tonix Pharmaceuticals Holding develops pharmaceutical products for central nervous system disorders.
The vaccine is a modified horsepox virus developed using Tonix’s proprietary horsepox vaccine platform. TNX-1800 is designed to express a protein derived from the virus that causes the coronavirus infection. Southern Research will be responsible for evaluating the efficacy of the vaccine, under the partnership.
The vaccine is a modified horsepox virus developed using Tonix’s proprietary horsepox vaccine platform. TNX-1800 is designed to express a protein derived from the virus that causes the coronavirus infection. Southern Research will be responsible for evaluating the efficacy of the vaccine, under the partnership.
Technology:
COVID
Industry:
Vaccine/Drug
Headquarters:
United States
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership